Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA. |
|
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ciaramella Giuseppe | President | Nov 06 '24 | Sale | 26.36 | 51,110 | 1,347,050 | 109,150 | Nov 08 04:10 PM | Ciaramella Giuseppe | President | Oct 14 '24 | Option Exercise | 2.00 | 41,754 | 83,594 | 211,370 | Oct 16 04:44 PM | Ciaramella Giuseppe | President | Oct 14 '24 | Sale | 26.27 | 51,110 | 1,342,752 | 160,260 | Oct 16 04:44 PM | Giuseppe Ciaramella | Officer | Oct 14 '24 | Proposed Sale | 24.65 | 102,220 | 2,519,723 | | Oct 15 11:37 AM | Burrell Terry-Ann | Officer | Oct 07 '24 | Proposed Sale | 23.00 | 185,565 | 4,267,995 | | Oct 07 05:00 PM | Bellon Christine | Chief Legal Officer | Oct 01 '24 | Sale | 23.48 | 385 | 9,040 | 104,209 | Oct 02 05:52 PM | Cavanagh Bethany J | SVP, Finance and Treasurer | Oct 01 '24 | Sale | 23.48 | 289 | 6,785 | 44,931 | Oct 02 05:51 PM | Evans John M. | CEO | Sep 30 '24 | Sale | 24.60 | 60,000 | 1,476,024 | 938,659 | Oct 02 05:49 PM | JOHN M EVANS | Officer | Sep 30 '24 | Proposed Sale | 24.60 | 60,000 | 1,476,024 | | Sep 30 04:51 PM | Simon Amy | Chief Medical Officer | Jul 02 '24 | Sale | 22.95 | 748 | 17,167 | 68,805 | Jul 03 04:05 PM | Simon Amy | Chief Medical Officer | Jul 01 '24 | Sale | 23.76 | 502 | 11,928 | 69,553 | Jul 03 04:05 PM | Evans John M. | CEO | Jun 27 '24 | Sale | 24.50 | 60,000 | 1,470,156 | 998,343 | Jun 28 04:15 PM | Simon Amy | Chief Medical Officer | Apr 02 '24 | Sale | 30.54 | 16,530 | 504,851 | 70,060 | Apr 03 07:43 PM | Simon Amy | Chief Medical Officer | Apr 01 '24 | Sale | 32.13 | 7,157 | 229,954 | 86,590 | Apr 03 07:43 PM | Bellon Christine | Chief Legal Officer | Apr 01 '24 | Sale | 32.12 | 3,401 | 109,240 | 104,594 | Apr 03 07:40 PM | Burrell Terry-Ann | Chief Financial Officer | Apr 01 '24 | Sale | 32.12 | 5,446 | 174,926 | 70,137 | Apr 03 07:39 PM | Evans John M. | CEO | Apr 01 '24 | Sale | 32.13 | 18,102 | 581,617 | 1,058,343 | Apr 03 07:36 PM | Ciaramella Giuseppe | President | Apr 01 '24 | Sale | 32.12 | 4,534 | 145,632 | 169,616 | Apr 03 07:33 PM | Evans John M. | CEO | Mar 28 '24 | Sale | 33.86 | 60,000 | 2,031,402 | 998,262 | Apr 01 04:10 PM | FMR LLC | See Remark 1 | Feb 14 '24 | Sale | 30.55 | 900,000 | 27,496,912 | 1,235,511 | Feb 15 02:34 PM | FMR LLC | See Remark 1 | Feb 13 '24 | Sale | 30.76 | 1,565 | 48,139 | 2,771,913 | Feb 15 02:34 PM | Evans John M. | CEO | Jan 31 '24 | Sale | 25.33 | 60,000 | 1,519,800 | 1,058,262 | Feb 02 04:05 PM | Bellon Christine | Chief Legal Officer | Jan 03 '24 | Sale | 26.42 | 1,907 | 50,383 | 80,495 | Jan 05 04:30 PM |
|